Literature DB >> 11868933

Insights into the immunopathogenesis of multiple sclerosis.

Niels Hellings1, Jef Raus, Piet Stinissen.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). Significant progress has been made in our understanding of the etiology of MS. MS is widely believed to be an autoimmune disease that results from aberrant immune responses to CNS antigens. T cells are considered to be crucial in orchestrating an immunopathological cascade that results in damage to the myelin sheath. This review summarizes the currently available data supporting the idea that myelin reactive T cells are actively involved in the immunopathogenesis of MS. Some of the therapeutic strategies for MS are discussed with a focus on immunotherapies that aim to specifically target the myelin reactive T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11868933     DOI: 10.1385/IR:25:1:27

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  199 in total

1.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.

Authors:  Z X Zhang; L Yang; K J Young; B DuTemple; L Zhang
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  A full genome search in multiple sclerosis.

Authors:  G C Ebers; K Kukay; D E Bulman; A D Sadovnick; G Rice; C Anderson; H Armstrong; K Cousin; R B Bell; W Hader; D W Paty; S Hashimoto; J Oger; P Duquette; S Warren; T Gray; P O'Connor; A Nath; A Auty; L Metz; G Francis; J E Paulseth; T J Murray; W Pryse-Phillips; R Nelson; M Freedman; D Brunet; J P Bouchard; D Hinds; N Risch
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 3.  The small heat shock protein alpha B-crystallin as key autoantigen in multiple sclerosis.

Authors:  J M Van Noort; A C van Sechel; M J van Stipdonk; J J Bajramovic
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

4.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Authors:  A E Lovett-Racke; J L Trotter; J Lauber; P J Perrin; C H June; M K Racke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

5.  Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats.

Authors:  C Brunner; H Lassmann; T V Waehneldt; J M Matthieu; C Linington
Journal:  J Neurochem       Date:  1989-01       Impact factor: 5.372

6.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

Authors:  B L Kotzin; S Karuturi; Y K Chou; J Lafferty; J M Forrester; M Better; G E Nedwin; H Offner; A A Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection.

Authors:  E Merelli; P Sola; P Barozzi; G Torelli
Journal:  J Neurol Sci       Date:  1996-04       Impact factor: 3.181

8.  Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis.

Authors:  F Zipp; M Kerschensteiner; K Dornmair; J Malotka; S Schmidt; A Bender; G Giegerich; R de Waal Malefyt; H Wekerle; R Hohlfeld
Journal:  Brain       Date:  1998-08       Impact factor: 13.501

9.  Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.

Authors:  K Banki; E Colombo; F Sia; D Halladay; D H Mattson; A H Tatum; P T Massa; P E Phillips; A Perl
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.

Authors:  K W Wucherpfennig; A Sette; S Southwood; C Oseroff; M Matsui; J L Strominger; D A Hafler
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  25 in total

1.  Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis.

Authors:  Alfredo Prieto; David Díaz; Hugo Barcenilla; Carmen Castrillo; Jorge Monserrat; Antonio García Merino; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

2.  The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.

Authors:  J M Greer; M P Pender
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

Review 3.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

4.  High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system.

Authors:  Silke Timmermans; Jeroen F J Bogie; Tim Vanmierlo; Dieter Lütjohann; Piet Stinissen; Niels Hellings; Jerome J A Hendriks
Journal:  J Neuroimmune Pharmacol       Date:  2013-09-26       Impact factor: 4.147

5.  The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.

Authors:  Rina Aharoni; Raya Eilam; Hagit Domev; Galya Labunskay; Michael Sela; Ruth Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 6.  Invariant natural killer T cells and their ligands: focus on multiple sclerosis.

Authors:  Joan O'Keeffe; Maria Podbielska; Edward L Hogan
Journal:  Immunology       Date:  2015-06-25       Impact factor: 7.397

7.  Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis.

Authors:  Oscar A Bizzozero; Gisela DeJesus; Heather A Bixler; Andrzej Pastuszyn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

8.  Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine.

Authors:  V Calabrese; G Scapagnini; A Ravagna; R Bella; D A Butterfield; M Calvani; G Pennisi; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

Review 9.  Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders.

Authors:  Ruth Arnon; Rina Aharoni
Journal:  Mol Neurobiol       Date:  2007-10-11       Impact factor: 5.590

10.  Exposure of rat optic nerves to nitric oxide causes protein S-nitrosation and myelin decompaction.

Authors:  Oscar A Bizzozero; Gisela DeJesus; Tamara A Howard
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.